Recombinant Human ABCG4 protein, His & T7-tagged
Cat.No. : | ABCG4-8153H |
Product Overview : | Recombinant Human ABCG4 aa. (Val59~Thr301 (Accession # Q9H172)) fused with N-terminal His & T7 tag was produced in E. coli cells. |
- Specification
- Gene Information
- Related Products
Source : | E. coli |
Species : | Human |
Tag : | His & T7 |
Form : | Freeze-dried powder |
Molecular Mass : | Predicted Molecular Mass: 30.7kDa. |
Protein length : | Val59~Thr301 (Accession # Q9H172) |
Endotoxin : | <1.0EU per 1ug (determined by the LAL method) |
Purity : | >95% |
Characteristic : | The isoelectric point is 9.3. |
Applications : | SDS-PAGE; WB; ELISA; IP. |
Stability : | The thermal stability is described by the loss rate of the target protein. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. (Referring from China Biological Products Standard, which was calculated by the Arrhenius equation.) The loss of this protein is less than 5% within the expiration date under appropriate storage condition. |
Storage : | Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months. |
Storage Buffer : | Supplied as lyophilized form in 20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% sarcosyl, 5% trehalose, and preservative. |
Reconstitution : | Reconstitute in sterile ddH2O. |
Gene Name : | ABCG4 ATP binding cassette subfamily G member 4 [ Homo sapiens (human) ] |
Official Symbol : | ABCG4 |
Synonyms : | ABCG4; ATP binding cassette subfamily G member 4; WHITE2; ATP-binding cassette sub-family G member 4; ATP-binding cassette, sub-family G (WHITE), member 4; putative ABC transporter |
Gene ID : | 64137 |
mRNA Refseq : | NM_001142505.1 |
Protein Refseq : | NP_001135977.1 |
UniProt ID : | Q9H172 |
Products Types
◆ Recombinant Protein | ||
ABCG4-068H | Recombinant Human ABCG4 Protein, GST-Tagged | +Inquiry |
ABCG4-0071H | Recombinant Human ABCG4 Protein (Val59-Thr301), N-His-tagged | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (21)
Ask a questionABCG4 expression was regulated redox-dependently by intracellular glutathione (GSH) levels
ABCG4 has been implicated in neurodegenerative diseases, including Alzheimer's disease. It is thought to be involved in the efflux of lipids and cholesterol from brain cells, contributing to lipid homeostasis and potentially influencing the pathogenesis of these diseases.
The heterodimerization of ABCG1 and ABCG4 indicates their ability to interact and form complexes. This interaction might be essential for their proper function or regulation.
Doxorubicin (Dox)‐induced ABCG4 upregulation causes prostate cancer (PCa) chemoresistance
The exact substrates of ABCG4 in the context of drug resistance are still being investigated. While ABCG4's involvement in mediating drug resistance has been established, the specific drugs or compounds that it transports have not been conclusively identified.
Glutathione levels dictate ABCG4 expression in androgen‐independent PCa cells.
The specific genetic or epigenetic factors influencing ABCG4-mediated drug resistance have not been extensively studied. However, it is possible that genetic variations or alterations in epigenetic marks could impact ABCG4 expression or function, potentially contributing to drug resistance.
Strategies such as targeted therapies or combination treatments may be investigated to inhibit ABCG4 expression or activity, with the aim of overcoming drug resistance and improving treatment outcomes.
Statins sensitize androgen‐independent PCa cells to Dox by inhibiting ABCG4 levels.
In the present study, we documented that doxorubicin (Dox) or cisplatin‐induced prostate cancer (PCa) chemoresistance is predominantly mediated by the induction of ABCG4 in androgen‐independent PCa cells.
The regulation of ABCG4 expression in NSCLC is not fully understood. However, studies suggest that various factors, including transcriptional regulators, signaling pathways, and microenvironmental cues, can influence ABCG4 expression.
The presence of genetic variants or mutations in ABCG4 has not been extensively studied for disease susceptibility. However, it is possible that variations in the ABCG4 gene sequence could affect its function or expression, potentially influencing disease susceptibility.
ABCG4-mediated drug resistance may involve the efflux of specific drugs or a broader range of compounds. The substrate specificity of ABCG4 is still being elucidated, and it is possible that it can transport multiple drugs or compounds.
Targeting ABCG4 is being explored as a potential strategy to overcome drug resistance in NSCLC. By inhibiting or modulating ABCG4 activity, it may be possible to prevent drug efflux and enhance the effectiveness of chemotherapy.
The specific mechanisms by which ABCG4 contributes to drug resistance in NSCLC are not yet fully understood. However, it is hypothesized that ABCG4 actively transports drugs out of cancer cells, preventing their accumulation and reducing their cytotoxic effects.
The sequence similarity of 69% between ABCG1 and ABCG4 suggests a close evolutionary relationship and potential functional similarities. This similarity may indicate shared structural and functional features that enable them to perform similar roles in cellular processes.
The regulation of ABCG4 expression and activity in the context of drug resistance is not yet fully understood. It is likely that various factors, such as genetic and epigenetic mechanisms, signaling pathways, and microenvironmental cues, influence ABCG4 expression and activity.
ABCG4 has been implicated in mediating drug resistance in non-small-cell lung cancer (NSCLC). It is likely that ABCG4 functions as an efflux transporter, pumping out anti-cancer drugs from cancer cells and reducing their effectiveness. This can contribute to treatment resistance and hinder the success of chemotherapy.
ABCG4 is regulated via NF‐kB‐c‐Myc‐cAMP‐regulatory element‐binding protein axis in androgen‐independent PCa cells.
ABCG4 play a role in Dox-mediated chemoresistance, and as a potential therapeutic target in drug-induced PCa
ABCG4 plays a role in cellular cholesterol homeostasis by facilitating the efflux of cholesterol from cells. Its expression levels can affect the balance between cholesterol influx and efflux, thereby influencing cellular cholesterol levels and lipid metabolism.
Customer Reviews (5)
Write a reviewThe availability of online resources, including FAQs and troubleshooting guides, proved helpful when encountering any challenges during my research.
he protein product maintained its activity over an extended period, allowing for long-term experiments without compromising performance
I conducted a side-by-side comparison with other protein products, and the superior quality of this product was evident in terms of purity and functionality
The company provided technical datasheets, protocols, and application notes.
The protein product underwent stringent quality control tests, ensuring the absence of endotoxins and other contaminants that could affect my assays
Ask a Question for All ABCG4 Products
Required fields are marked with *
My Review for All ABCG4 Products
Required fields are marked with *
Inquiry Basket